Volume 7, Issue 1 (6-2024)
Mod Med Lab J 2024, 7(1): 100-100 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Inc. F. Niosomes as brucellosis vaccine candidates. Mod Med Lab J 2024; 7 (1) :100-100
URL: http://modernmedlab.com/article-1-121-en.html
URL: http://modernmedlab.com/article-1-121-en.html
Abstract: (116 Views)
Aims: Niosomes are vesicles, a new drug delivery system, which can be It is used for sustained, controlled as well as targeted delivery of drugs. Niosomes are vesicles, a new drug delivery system, which can be They are used for sustained, controlled as well as targeted delivery of drugs and as vaccine candidates. The aim of this study was to evaluate host response to niosomes containing chimeric protein as candidate for brucellosis vaccine.
Materials & Methods: This study was experimentally designed in 2020 on 50 balb/c mice. These mice were randomly divided into different injection, oral and inhalation groups.
Findings: This study successfully announced that the niosomal form has better efficacy and better safety performance in Brucella vaccine design.
Conclusions: Niosomes are a drug delivery system that can be used as Controlled, sustained and targeted delivery of drugs like vaccines
Materials & Methods: This study was experimentally designed in 2020 on 50 balb/c mice. These mice were randomly divided into different injection, oral and inhalation groups.
Findings: This study successfully announced that the niosomal form has better efficacy and better safety performance in Brucella vaccine design.
Conclusions: Niosomes are a drug delivery system that can be used as Controlled, sustained and targeted delivery of drugs like vaccines
Type of Study: Original Research Article |
Subject:
Clinical Microbiology
References
1. Zhou G, Wang S, Liao C, Wang L, Huang M. A pilot study of differential gene expressions in patients with cough variant asthma and classic bronchial asthma. J Asthma. 2022;59(6):1070-8. [DOI:10.1080/02770903.2021.1917604] [PMID]
2. Huo Y, Zhang HY. Genetic mechanisms of asthma and the implications for drug repositioning. Genes (Basel). 2018;9(5):237. [DOI:10.3390/genes9050237] [PMID] [PMCID]
3. Sharifi A, Ghadiri A, Salimi A, Ghandil P, Esmaeili SA. Evaluating the distribution of (+2044G/A, R130Q) Rs20541 and (-1112 C/T) Rs1800925 polymorphism in IL-13 gene: an association-based study with asthma in Ahvaz, Iran. Int J Med Lab. 2021;8(3):193-202. [DOI:10.18502/ijml.v8i1.5675]
4. Pelaia C, Heffler E, Crimi C, Maglio A, Vatrella A, Pelaia G, et al. Biological therapy of severe asthma with dupilumab, a dual receptor antagonist of interleukin-4 and 13. Vaccines (Basel). 2022;10(6):974. [DOI:10.3390/vaccines10060974] [PMID] [PMCID]
5. Zaki NW, Al-Qahtani AS, Al-Khars MA, Al-Muzairai IA, Al-Otaibi SM, Al-Enezi AS, et al. Stress and psychological consequences of COVID-19 on health-care workers. J Nat Sci Med. 2020;3(4):299-307.
6. Chinn S, Jarvis D, Burney P, Luczynska C, Ackermann-Liebrich U, Alkiewicz J, et al. Increase in diagnosed asthma but not in symptoms in the European Community Respiratory Health Survey. Thorax. 2004;59(8):646-51. [DOI:10.1136/thx.2004.021642] [PMID] [PMCID]
7. Hussein N, Kamal R, Hanna C. Association of IL4 gene polymorphism with asthma severity among Egyptian patients. Minia J Med Res. 2020;31(2):303-7. [DOI:10.21608/mjmr.2022.221079]
8. Dimitrova D, Youroukova V, Ivanova-Todorova E, Tumangelova-Yuzeir K, Velikova T. Serum levels of IL-5, IL-6, IL-8, IL-13, and IL-17A in pre-defined groups of adult patients with moderate and severe bronchial asthma. Respir Med. 2019;154:144-54. [DOI:10.1016/j.rmed.2019.06.024] [PMID]
9. Zhang JH, Zhang M, Wang YN, Zhang XY. Correlation between IL-4 and IL-13 gene polymorphisms and asthma in Uyghur children in Xinjiang. Exp Ther Med. 2018;16(2):1435-42. [DOI:10.3892/etm.2018.7096]
10. Noureldin M, El-Sahrigy S, El-Ganzoury M, Bakr A. Association of Interleukin 13 +2044G/A polymorphism with bronchial asthma development, severity, and immunoglobulin E levels in an Egyptian population. Clin Med Diagn. 2014;4(4):71-7.
11. Li L, Liang J, Han J, Wang G, Zhang X, Li G, et al. Role of interleukin-4 genetic polymorphisms and environmental factors in the risk of asthma in children. Genet Mol Res. 2016;15(4):gmr15048995. [DOI:10.4238/gmr15048873]
12. Afshari JT, Reed W, Ghaffari J, Abbasinazari M. Association of the expression of IL-4 and IL-13 genes, IL-4 and IgE serum levels with allergic asthma. Iran J Allergy Asthma Immunol. 2007;6(2):67-72.
13. Liu Y, Liao J, Chen S, Chen L. The -33C/T polymorphism in the interleukin 4 gene is associated with asthma risk: a meta-analysis. J Investig Allergol Clin Immunol. 2014;24(2):114-21.
14. Davoodi P, Vijay Sagar AJ, Ramachandra NB. A preliminary study on the association of single-nucleotide polymorphisms of interleukin 4 (IL4), IL13, IL4 receptor alpha (IL4Rα), & toll-like receptor 4 (TLR4) genes with asthma in Indian adults. Indian J Med Res. 2015;142(6):675-80. [DOI:10.4103/0971-5916.174551] [PMID] [PMCID]
15. Hameed R, Kareem S, Al-Fadhil M. Study of serum interleukin 5 level and factors that impact this level in Iraqi asthmatic children. Biomed Biotechnol Res J. 2019;3(4):249-53. [DOI:10.4103/bbrj.bbrj_126_19]
16. Baye TM, Butsch Kovacic M, Biagini Myers JM, Martin LJ, Lindsey M, He H, et al. Differences in candidate gene association between European ancestry and African American asthmatic children. PLoS One. 2011;6(2):e16522. [DOI:10.1371/journal.pone.0016522] [PMID] [PMCID]
17. Ambrocio-Ortiz E, Pérez-Rubio G, Ramírez-Venegas A, Del-Río-Navarro B, Flores-Alfaro E, Falfán-Valencia R. Single-nucleotide and copy-number variants in IL4 and IL13 are not associated with asthma susceptibility or inflammatory markers: a case-control study in a Mexican-mestizo population. Diagnostics (Basel). 2020;10(5):317. [DOI:10.3390/diagnostics10050273] [PMID] [PMCID]
18. Imraish A, Abu-Thiab T, Zihlif M. IL-13 and FOXO3 gene polymorphisms regulate IgE levels in asthmatic patients. Biomed Rep. 2021;14(6):53. [DOI:10.3892/br.2021.1431] [PMID] [PMCID]
19. Afreen A, Al-Arabi S, Al-Malki S, Al-Wuhush S. Single-nucleotide polymorphism in the interleukin-4 promoter region and risk of asthma: TT homozygotes may have a high propensity to develop chronic airway remodelling. World J Adv Res Rev. 2020;7(9):104-10.
20. Kabesch M, Schedel M, Carr D, Woitsch B, Fritzsch C, Weiland SK, et al. The genetics of the IL-4/IL-13 pathway strongly influences serum IgE levels and the risk of childhood asthma. J Allergy Clin Immunol. 2006;117(2):269-74. [DOI:10.1016/j.jaci.2005.10.024] [PMID]
21. Wang ZD, Hou XR, Shen LP, Li JX. Association between the interleukin-4, interleukin-13 polymorphisms and asthma: a meta-analysis. Mol Biol Rep. 2013;40(2):1365-76. [DOI:10.1007/s11033-012-2180-0] [PMID]
22. Hussein IA, Jaber SH. Genotyping of IL-4 -590 (C>T) gene in Iraqi asthma patients. Dis Markers. 2017;2017:4738515. [DOI:10.1155/2017/5806236] [PMID] [PMCID]
23. Palikhe NS, Kim SH, Park HS. IL-13 gene polymorphisms are associated with rhinosinusitis and eosinophilic inflammation in aspirin-intolerant asthma. Allergy Asthma Immunol Res. 2010;2(2):134-40. [DOI:10.4168/aair.2010.2.2.134] [PMID] [PMCID]
24. Hunninghake GM, Soto-Quirós ME, Avila L, Su J, Murphy A, Demeo DL, et al. Polymorphisms in IL-13, total IgE, eosinophilia, and childhood asthma exacerbations. J Allergy Clin Immunol. 2007;120(1):84-90. [DOI:10.1016/j.jaci.2007.04.032] [PMID] [PMCID]
25. Xu Y, Liao B, Fu J. Association between IL-13 +1923C/T polymorphism and asthma risk: a meta-analysis based on 26 case-control studies. Biosci Rep. 2017;37(1):BSR20160416. [DOI:10.1042/BSR20160505] [PMID] [PMCID]
26. Jebur MS, Saud AM. Serum levels of total IgE and interleukin-13 in a sample of allergic asthma patients in Baghdad. Iraqi J Sci. 2020;61(12):3208-14. [DOI:10.24996/ijs.2020.61.12.8]
27. Elsaid A, Abdel-Aziz AF, Abdel-Ghani M, El-Sahrigy S. Polymorphisms in the interleukin-4 and interleukin-4 receptor genes and the risk of bronchial asthma among Egyptian children. Clin Biochem. 2021;93:66-72. [DOI:10.1016/j.clinbiochem.2021.04.006] [PMID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
